Explore answers to our most commonly asked questions about CBD, our products, and more.
GLP-3 is not a standard pharmacology name; on research-vendor sites it is used as shorthand for a multi-incretin research compound that acts on more than one metabolic receptor pathway. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
In published laboratory work, multi-incretin research compounds of this class are studied for receptor-signaling behaviour across more than one metabolic pathway, for comparative potency against single-pathway incretin peptides, and for analytical characterization such as purity, identity and stability testing. All material sold here is supplied for research use only and is not intended for human or animal use, diagnosis, or treatment.
Subscribe to receive your promo code and occasional email updates about new research materials.
By subscribing, you agree to our Privacy and Cookie Policy and Terms & Conditions.
Our agents are here to help you.
The products on this website are for legitimate research use only. They are not intended to prevent, treat, or cure any illness or disease and are not intended for human consumption. By accessing this site, you acknowledge that you are at least 21 years of age, understand these terms, and have a legitimate research basis for buying these products.
NOTE: All of our compounds are sold individually and are supplied as research materials only. Laboratory consumables are not included, and we do not provide reconstitution, administration, or human-use instructions.
